Last reviewed · How we verify
NCT06348589
Orthostatic Hypotension and Blood Pressure Variability in Persons Undergoing Hemodialysis
trial in Chronic Kidney Disease Requiring Chronic Dialysis in 25 participants. Completed in 30 August 2024.
30 August 2024
Quick facts
| Lead sponsor | Vrinnevi Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 8 April 2024 |
| Primary completion | 30 August 2024 |
| Estimated completion | 30 August 2024 |
| Sites | 1 location across Sweden |
Conditions studied
- Chronic Kidney Disease Requiring Chronic Dialysis — all drugs for Chronic Kidney Disease Requiring Chronic Dialysis →
Sponsor
Vrinnevi Hospital
Who can join
Eligibility, any sex, with Chronic Kidney Disease Requiring Chronic Dialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
High blood pressure is a risk factor for end-stage renal disease and is common in patients undergoing maintenance hemodialysis. Intradialytic hypotension is associated with an adverse prognosis. More knowledge is needed to identify patients at high risk for intradialytic hypotension and dialysis-associated hypotensive episodes. The aim of this observational single-center pilot study is to evaluate whether point-of-care ultrasound measurements may predict intradialytic hypotension and orthostatic blood pressure falls, in patients with chronic kidney disease who undergo maintenance hemodialysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06348589
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Kidney Disease Requiring Chronic Dialysis
Currently open trials in the same condition.
- NCT07332949 — Impact of Dialysis on Sexuality. · recruiting
- NCT06873880 — Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients · recruiting
- NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
- NCT06591702 — Investigation of the Validity, Reliability, and Responsiveness of BETY-BQ in Chronic Kidney Disease, on Dialysis, and Ki · recruiting
- NCT06040281 — Smart and Fit for Kidney Transplantation · NA · recruiting
Other Vrinnevi Hospital trials
Trials by the same sponsor.
- NCT07347093 — Reversal of Roux-en-Y Gastric Bypass: A Swedish National Cohort Study · active not recruiting
- NCT06933303 — Distraction as Treatment for Pain in Children in Resource-scarce Settings · NA · recruiting
- NCT06399666 — Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation · recruiting
- NCT03490305 — Penetrating Abdominal Injuries From the Battle of Mosul · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06348589 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vrinnevi Hospital
- Last refreshed: 14 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06348589.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing